EGFR and cutaneous melanoma: ERBB1/2/3 are associated with infiltration of multiple immune cells, especially the M1 Macrophage, Dendritic cell, Th1, Th2, Th17, and Treg cells, which suggests that ERBBs may affect survival rate in cutaneous melanoma patients by affecting immune cell infiltration.